Despite the finding that percent Galectin-3 and MHC-II coverage in microglia is not different between treatment groups in the cortex using immunofluorescence, a clear dose-dependent increase in protein levels is observed in concentric rings around amyloid plaques for both proteins (Fig. 6D, F). The gene discussed is LGALS3; the disease is amyloidosis.